Effectiveness of Combined Treatment of Carboxytherapy, Platelet-Rich Plasma (PRP) and Local Finasteride with Platelet-Rich Plasma in the Treatment of Androgenic Hair Loss

Comparing the Effectiveness of Combined Treatment of Carboxy Therapy, Platelet-Rich Plasma (PRP) and Topical Finasteride with Platelet-Rich Plasma Plus Topical Finasteride, in the Treatment of Male Pattern Androgenic Hair Loss

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220919055994N1

Enrollment

Registered

2023-05-26

Start date

2023-07-21

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic hair loss. Cicatricial alopecia [scarring hair loss]

Interventions

Intervention 1: The First Group Receiving PRP. Intervention 2: Intervention group: The second group receiving PRP along with Carboxytherapy.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: It is Men Who Have Suffered Androgenic Hair Loss (Severity 2-4 according to the Hamilton-Norwood Criteria) without any Underlying Disease

Exclusion criteria

Exclusion criteria: Patients include Platelet Disorders, Thrombocytopenia, Anemia, Cardio-Pulmonary Diseases, Kidney Disease, Vasovagal Syncope, Uncontrolled Blood Pressure, Taking Anticoagulant Drugs, Thyroid Dysfunction, Diabetes, Sepsis.

Design outcomes

Primary

Measure	Time frame
Male Hair Loss. Timepoint: 3 Months. Method of measurement: PhotoFinder Device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Rastaghi

Kerman University of Medical Sciences

fatemeh_rastaghi@yahoo.com+98 34 3132 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026